Gen XY Updates from GlobeNewswire
2026-01-16T06:00:02Z
PALO ALTO, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”), a new type of biopharmaceutical company focused on genetic diseases, announced...
2026-01-16T01:22:25Z
NeuroXen Editorial Report: "Strongest Adderall Alternative" Reflects Consumer Search Language in 2026 and Does Not Indicate Ranking, Endorsement, Equivalence to Adderall, or Product Effectiveness
2026-01-15T22:29:06Z
Phen24 Editorial Report: OTC Appetite Suppressants, Natural Weight Loss Pills, Prescription vs Supplement Standards, and the 7-Point Consumer Verification Framework
2026-01-15T22:10:48Z
Etan Bendheim assumes role of CEO and Mark Warner moves to CTO role
2026-01-15T21:30:00Z
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ("IND") candidate, SER-252, for...
2026-01-15T21:05:00Z
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel...
2026-01-15T21:03:00Z
IRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to...
2026-01-15T21:01:00Z
All resolutions passed, enabling the Company to streamline regulatory and operational processes
2026-01-15T19:30:00Z
GRAND PRAIRIE, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center, a leading addiction rehab center in Dallas has added a new Harvard-trained physician, Dr. Queeneth Uwandu, MD, to its...
2026-01-15T18:50:59Z
Independent Research Examines Nano Microneedle Technology, Bioavailability Science, and Consumer Evaluation Criteria for Transdermal NAD+ and Berberine Formats
2026-01-15T18:39:44Z
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- As metabolism supplements continue to grow in popularity in 2026, many consumers are seeking clear, factual information to better understand...
2026-01-15T18:00:00Z
No Shareholder Action Required at This Time
2026-01-15T17:46:28Z
Fourth-generation leadership grows managed communities from 13 to 24 and licenses SNFiQ/SLiQ to 70 senior care locations in the first year
2026-01-15T17:28:00Z
16-bed crisis triage center is the final program to launch in new state-of-the-art facility, following the December 2025 opening of the 16-bed Evaluation and Treatment Unit (E&T)
2026-01-15T17:26:22Z
Cabana Live Offers Confidential Peer Support Services with No Out-of-Pocket Costs
2026-01-15T17:07:00Z
New Independent Non-Profit Uses Cutting-Edge Certification Technology to Provide ISO-aligned ID to Assistance Dog Teams
2026-01-15T17:00:00Z
Issy-les-Moulineaux, January 15, 2026
2026-01-15T17:00:00Z
Lotto.com reaches 4 million customers and over $150M in winnings in under five years
2026-01-15T16:46:07Z
CHICAGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces the addition of seven new institutions to its growing FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA): University...
2026-01-15T16:23:40Z
HOLLYWOOD, Fla., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Emerald Cruises & Tours has reached a significant milestone in the build of Emerald Kaia, following the successful completion of sea trials in Halong Bay, Vietnam. This major...
2026-01-15T14:31:20Z
NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit solely focused on accelerating a cure for type 1 diabetes, announced the release of...
2026-01-15T14:30:00Z
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE15 JANUARY 2026 at 16:30 EET
2026-01-15T14:15:00Z
New Year’s resolutions that focus on addition, not restriction, may help more people stick with them
2026-01-15T14:01:00Z
STÄFA, Switzerland, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in innovative hearing solutions, today announced that Virto R Infinio has been named an Innovative Product Winner in...
2026-01-15T14:00:00Z
Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding
2026-01-15T14:00:00Z
LAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC: GLXZ), the world’s largest independent developer and distributor of casino table games and technology, is set to make...
2026-01-15T14:00:00Z
CHARLOTTE, N.C., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing precision cancer therapies with targeted delivery to the brain...
2026-01-15T14:00:00Z
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing,...
2026-01-15T13:45:00Z
The Science, Clinical Promise, & Market Outlook
2026-01-15T13:38:00Z
Partnership advances marketing strategy in preparation for pending launch of recently announced entry into Prediction Markets
2026-01-15T13:30:00Z
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market
2026-01-15T13:30:00Z
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company...
2026-01-15T13:15:00Z
MALVERN, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced positive preliminary...
2026-01-15T13:01:00Z
WASHINGTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- 60 Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne...
2026-01-15T13:00:00Z
Company Shared Poster on Breakthrough Genetic Stratification Data from Positive Phase 2b OLIVE Trial Results for BH-200
2026-01-15T13:00:00Z
MARKHAM, Ontario, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of...
2026-01-15T13:00:00Z
SAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) -- ViroMissile, Inc., a cancer immunotherapy company pioneering the IDOV™ (Intravenously Deliverable Oncolytic Virus) platform, today announced the appointment of Michael G. Wood...
2026-01-15T13:00:00Z
High Roller plans to introduce Web3-enabled incentives to reshape player engagement.
2026-01-15T13:00:00Z
STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product, Jornay PM...
2026-01-15T13:00:00Z
Vaccine was safe and well-tolerated and led to a significant increase in norovirus-specific antibodies in serum and breast milk
2026-01-15T13:00:00Z
Combines AI-Powered Technology with R1 Experts to Set a New Standard for Clearance and Denial Rates
2026-01-15T13:00:00Z
Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in Shenzhen
2026-01-15T12:30:00Z
Among monotherapy expansion cohorts (n=21), ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for...
2026-01-15T12:30:00Z
Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function
2026-01-15T12:00:00Z
Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, 2029
2026-01-15T12:00:00Z
This milestone marks significant progress in the first-in-human evaluation of AAVantgarde’s dual-AAV gene therapy designed to address the underlying cause of vision loss in patients with USH1B
2026-01-15T12:00:00Z
NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...
2026-01-15T12:00:00Z
Recently IND-Cleared HER2 × CD3 T-Cell Engager Highlighted by Global Biopharmaceutical Partner
2026-01-15T11:23:12Z
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD...
2026-01-15T08:26:00Z
Actuarial claims analysis confirms up to 9X ROI across GLP-1, Metabolic, and GI Costs, demonstrating the power of gut microbiome and genetics-based biomarker care
